SCHEDULE 13G/A

Inhibikase Therapeutics Inc

Common Stock, $0.001 par value · CUSIP: 45719W205

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Nantahala Capital Management, LLC

  Shares: 7,037,916.00 · Class: 5.68%

• Wilmot B. Harkey

  Shares: 7,037,916.00 · Class: 5.68%

• Daniel Mack

  Shares: 7,037,916.00 · Class: 5.68%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.